Literature DB >> 17695248

Dendritic cells and the immunopathogenesis of systemic lupus erythematosus.

Seetha Monrad1, Mariana J Kaplan.   

Abstract

Over the last decade, the role of dendritic cells (DCs) in the immunopathogenesis of systemic lupus erythematosus (SLE) has become apparent. As unique mediators of both tolerance and immunity, aberrant myeloid and plasmacytoid DC function can promote autoimmune responses via a number of mechanisms and proinflammatory pathways. This review provides an overview of DC function, the potential role of DCs in promoting autoimmune responses in SLE, and how other abnormalities in lupus can lead to an enhanced engagement of DCs in immune responses. How medications used to treat SLE and other autoimmune conditions may exert effects on DCs is also explored.

Entities:  

Mesh:

Year:  2007        PMID: 17695248     DOI: 10.1007/bf02685895

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  106 in total

1.  Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases.

Authors:  Wai-Kee Ip; Yu-Lung Lau
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

Review 2.  Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching.

Authors:  Andrea Cerutti; Xugang Qiao; Bing He
Journal:  Immunol Cell Biol       Date:  2005-10       Impact factor: 5.126

Review 3.  The role of interleukin-10 in systemic lupus erythematosus.

Authors:  Luis Llorente; Yvonne Richaud-Patin
Journal:  J Autoimmun       Date:  2003-06       Impact factor: 7.094

4.  Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes.

Authors:  Jianwei Li; Yang Liu; Chun Xie; Jiankun Zhu; Desi Kreska; Laurence Morel; Chandra Mohan
Journal:  Arthritis Rheum       Date:  2005-10

Review 5.  T- and B-cell abnormalities in systemic lupus erythematosus.

Authors:  Gyorgy Nagy; Agnes Koncz; Andras Perl
Journal:  Crit Rev Immunol       Date:  2005       Impact factor: 2.214

6.  Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells.

Authors:  Y Shoshan; I Shapira; E Toubi; I Frolkis; M Yaron; D Mevorach
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.

Authors:  Joerg Wenzel; Stephanie Henze; Sabine Brähler; Thomas Bieber; Thomas Tüting
Journal:  Exp Dermatol       Date:  2005-06       Impact factor: 3.960

8.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

9.  In vivo tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: the induction of a high level of autoantibodies but not renal pathological changes.

Authors:  Jau-Ling Suen; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 10.  Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.

Authors:  Terry K Means; Andrew D Luster
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

View more
  13 in total

1.  Polyclonal CD4+Foxp3+ Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome.

Authors:  Qin Lan; Xiaohui Zhou; Huimin Fan; Maogen Chen; Julie Wang; Bernhard Ryffel; David Brand; Rajalakshmy Ramalingam; Pawel R Kiela; David A Horwitz; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2012-07-06       Impact factor: 6.216

Review 2.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

3.  Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus.

Authors:  Paul Alves; Muhammad M Bashir; Maria Wysocka; Majid Zeidi; Rui Feng; Victoria P Werth
Journal:  J Investig Dermatol Symp Proc       Date:  2017-10

Review 4.  Innate pathways to B-cell activation and tolerance.

Authors:  Steve P Crampton; Elisaveta Voynova; Silvia Bolland
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 5.  Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies.

Authors:  Stefan Tukaj; Grzegorz Węgrzyn
Journal:  Cell Stress Chaperones       Date:  2016-01-20       Impact factor: 3.667

6.  Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation.

Authors:  Carla M Cuda; Alexander V Misharin; Angelica K Gierut; Rana Saber; G Kenneth Haines; Jack Hutcheson; Stephen M Hedrick; Chandra Mohan; G Scott Budinger; Christian Stehlik; Harris Perlman
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

7.  Identification of gp96 as a novel target for treatment of autoimmune disease in mice.

Authors:  Jung Min Han; Nam Hoon Kwon; Jin Young Lee; Seung Jae Jeong; Hee Jung Jung; Hyeong Rae Kim; Zihai Li; Sunghoon Kim
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

8.  Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.

Authors:  Hemant Agrawal; Noam Jacob; Esther Carreras; Sandra Bajana; Chaim Putterman; Sean Turner; Barbara Neas; Alexis Mathian; Michael N Koss; William Stohl; Susan Kovats; Chaim O Jacob
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

9.  Critical immunological pathways are downregulated in APECED patient dendritic cells.

Authors:  Nora Pöntynen; Mari Strengell; Niko Sillanpää; Juha Saharinen; Ismo Ulmanen; Ilkka Julkunen; Leena Peltonen
Journal:  J Mol Med (Berl)       Date:  2008-07-04       Impact factor: 4.599

Review 10.  Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models.

Authors:  Simanta Pathak; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2011-09-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.